Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation
Open accessThe DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Abstract
To maintain the homeostatic environment required for proper function of CNS neurons the endothelial cells of CNS microvessels tightly regulate the movement of ions and molecules between the blood and the CNS. The unique properties of these blood vascular endothelial cells are termed blood-brain barrier (BBB) and extend to regulating immune cell trafficking into the immune privileged CNS during health and disease. In general, extravasation of circulating immune cells is a multi-step process regulated by the sequential interaction of adhesion and signalling molecules between the endothelial cells and the immune cells. Accounting for the unique barrier properties of CNS microvessels, immune cell migration across the BBB is distinct and characterized by several adaptations. Here we describe the mechanisms that regulate immune cell trafficking across the BBB during immune surveillance and neuroinflammation, with a focus on the current state-of-the-art in vitro and in vivo imaging observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“More recently, the adhesion, tethering and rolling of lymphocytes on the blood–brain barrier (BBB) during the early phase of CNS invasion are also recognized as mediated by glycoproteins in Multiple Sclerosis (MS) and related disorders [72,73].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · cited 8×
“In accordance to the presence of complex and continuous TJs, T-cell diapedesis across the inflamed BBB has rather been observed to occur via a transcellular pathway, where the T cells form a pore through the endothelium and leave the complex TJs morphologically intact (9, 32, 89).”
BackgroundInfluentialZhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
Journal of Biological Chemistry
(2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,400
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Lawrence, M. B., & Springer, T. A. (1991) · Cell · doi:10.1016/0092-8674(91)90393-d · Cited by 2,129
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 1×
“This is shown by studies in claudin-5-deficient mice, which die perinatally (16), and by knockdown of endothelial claudin-5, which leads to cognitive impairment (17) (summarized in (18)).”
Background
Cited by
Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796288 · Cited by 432
“Therefore, future examination of how to traffic immune cells across the BBB could reveal the difference in healthy immune surveillance from NF&ND with diagnostic value (101).”
BackgroundThe neuroimmune axis of Alzheimer’s disease
Jorfi, M., Maaser-Hecker, A., & Tanzi, R. E. (2023) · Genome Medicine · doi:10.1186/s13073-023-01155-w · Cited by 292
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
Pediaditakis, I., Kodella, K. R., Manatakis, D. V., Le, C. Y., Hinojosa, C. D., Tien-Street, W., Manolakos, E. S., Vekrellis, K., Hamilton, G. A., Ewart, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26066-5 · Cited by 237
The Role of Viral Infections in the Onset of Autoimmune Diseases
Sundaresan, B., Shirafkan, F., Ripperger, K., & Rattay, K. (2023) · Viruses · doi:10.3390/v15030782 · Cited by 184
Age-related immune alterations and cerebrovascular inflammation
Finger, C. E., Moreno-Gonzalez, I., Gutierrez, A., Moruno-Manchon, J. F., & McCullough, L. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01361-1 · Cited by 173
How Does the Immune System Enter the Brain?
Mapunda, J. A., Tibar, H., Regragui, W., & Engelhardt, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.805657 · Cited by 161
“Rolling on the BBB allows T cells to interact with chemokines displayed on proteoglycans on the luminal surface of the endothelial cells via their specific GPCRs or possibly on ACKR1, leading to an inside-out-activation of integrins mediating the firm arrest of the immune cells on the luminal surface of the inflamed B…”
BackgroundBalasa, R., Barcutean, L., Mosora, O., & Manu, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168370 · Cited by 158
Perivascular spaces and their role in neuroinflammation
Ineichen, B. V., Okar, S. V., Proulx, S. T., Engelhardt, B., Lassmann, H., & Reich, D. S. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.024 · Cited by 158
Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis
Piehl, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13215 · Cited by 125
Wang, P., Yao, L., Luo, M., Zhou, W., Jin, X., Xu, Z., Yan, S., Li, Y., Xu, C., Cheng, R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00280-3 · Cited by 121
Macrophages on the margin: choroid plexus immune responses
Cui, J., Xu, H., & Lehtinen, M. K. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.07.002 · Cited by 119
A microengineered Brain-Chip to model neuroinflammation in humans
Pediaditakis, I., Kodella, K. R., Manatakis, D. V., Le, C. Y., Barthakur, S., Sorets, A., Gravanis, A., Ewart, L., Rubin, L. L., Manolakos, E. S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104813 · Cited by 88
“As expected, exposure to TNF-a induced significant changes in tight junction formation that compromised the barrier permeability and induced adhesion molecules such as ICAM-1, which propagated the inflammatory response by facilitating the recruitment of the immune cells to the brain (Marchetti and Engelhardt, 2020).”
BackgroundInfluentialBlood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models
Brandl, S., & Reindl, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612699 · Cited by 104
Advances and controversies in meningeal biology
Betsholtz, C., Engelhardt, B., Koh, G. Y., McDonald, D. M., Proulx, S. T., & Siegenthaler, J. A. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01701-8 · Cited by 98
“…and the glia limitans requires molecular mechanisms that are distinct from those required for T cell migration across the blood–brain barrier 106,107 . scRNAseq and functional studies have revealed the heterogeneity of borderassociated macrophages and emphasized their contribution to…”
Proulx, S. T., & Engelhardt, B. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13469 · Cited by 87
Lopez, J. A., Denkova, M., Ramanathan, S., Dale, R. C., & Brilot, F. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1316 · Cited by 83
“Recent decades have shed light upon the complexity of ongoing immune trafficking across the blood–brain and blood–cerebrospinal fluid (CSF) barriers.(2) This intricate interplay between the CNS and the immune system has highlighted the notion that certain neurological demyelinating disorders are attributable to an inf…”
BackgroundBlood–Brain Barrier Disruption in Neuroimmunological Disease
Shimizu, F., & Nakamori, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910625 · Cited by 75
“Hypoxia due to NVU dysfunction may be facilitated by mitochondrial dysfunction [29].”
BackgroundNair, A. L., Groenendijk, L., Overdevest, R., Fowke, T. M., Annida, R., Mocellin, O., de Vries, H. E., & Wevers, N. R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1250123 · Cited by 84
Galoppin, M., Kari, S., Soldati, S., Pal, A., Rival, M., Engelhardt, B., Astier, A., & Thouvenot, É. (2022) · Brain Communications · doi:10.1093/braincomms/fcac171 · Cited by 69
“tivated in the perivascular and subarachnoid CNS spaces by resident APCs allowing them to infiltrate the CNS parenchyma.(69,70)”
BackgroundInfluentialRemembering your A, B, C's: Alzheimer's disease and ABCA1
Lewandowski, C. T., Laham, M. S., & Thatcher, G. R. J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.011 · Cited by 76
Khaddour, K., Johanns, T. M., & Ansstas, G. (2020) · Pharmaceuticals · doi:10.3390/ph13110389 · Cited by 80
Castro Dias, M., Odriozola Quesada, A., Soldati, S., Bösch, F., Gruber, I., Hildbrand, T., Sönmez, D., Khire, T., Witz, G., McGrath, J. L., et al. (2021) · Journal of Cell Science · doi:10.1242/jcs.253880 · Cited by 75
“Accounting for the unique tightness of the BBB, multi-step T cell migration across the BBB is characterized by unique adaptations (Marchetti and Engelhardt, 2020).”
BackgroundImmunotherapy of glioblastoma: Recent advances and future prospects
Yuan, B., Wang, G., Tang, X., Tong, A., & Zhou, L. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2055417 · Cited by 81
“It is believed that this process provides the essential substrate for immunotherapy directed toward brain tumors.(14)”
BackgroundBlood-brain barrier permeability in the ischemic stroke: An update
Mathias, K., Machado, R. S., Stork, S. D. S., dos Santos, D., Joaquim, L. D. S., Generoso, J. S., Danielski, L. G., Barichello, T., Prophiro, J. S., & Petronilho, F. C. (2023) · Microvascular Research · doi:10.1016/j.mvr.2023.104621 · Cited by 84
Mapunda, J. A., Pareja, J. R., Vladymyrov, M., Bouillet, E., Hélie, P., Pleskač, P., Barcos, S., Andræ, J., Vestweber, D., McDonald, D. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41580-4 · Cited by 77
Therapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
“Immune cell trafficking into the CNS is tightly regulated by the BBB, permitting entry only for specific immune cell subsets 176 .”
Zhang, X., Wang, R., Chen, H., Jin, C., Jin, Z., Lu, J., Xu, L., Lu, Y., Zhang, J., & Shi, L. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00289-6 · Cited by 65
“The blood–brain barrier (BBB), which is composed of and regulated by endothelial cells, the basement membrane, pericytes, the glia limitans, and microglia, serves as a relay station between the circulation and the central nervous system (CNS) [8].”
BackgroundInfluentialImpact of epigenetic reprogramming on antitumor immune responses in glioma
McClellan, B. L., Haase, S., Núñez, F. J., Alghamri, M. S., Dabaja, A. A., Lowenstein, P. R., & Castro, M. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163450 · Cited by 85
“Inflammation within the brain has been shown to compromise BBB integrity (22, 23), allowing for increased immune cell infiltration, but by the time this occurs, gliomagenesis will likely have already escaped immune surveillance.”
Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB
Kimura, S., & Harashima, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121216 · Cited by 65
Khan, Z., Mehan, S., Gupta, G. D., & Narula, A. S. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.04.004 · Cited by 67
Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Suryawanshi, Y. R., & Schulze, A. J. (2021) · Viruses · doi:10.3390/v13071294 · Cited by 66
“These evidences represent a window of opportunity that requires exploration as it may be exploited to potentiate immune- and virotherapies in malignant glioma [93, 94].”
BackgroundAntigen recognition detains CD8+ T cells at the blood-brain barrier and contributes to its breakdown
Aydin, S., Pareja, J. R., Schallenberg, V. M., Klopstein, A., Gruber, T., Pagé, N., Bouillet, E., Blanchard, N., Liblau, R., Körbelin, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38703-2 · Cited by 75
Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics
Riessland, M., & Orr, M. E. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.104 · Cited by 52
“Since immune cell trafficking into the CNS is tightly regulated by the blood brain barrier which selectively only allows entry of immune cell subsets required for immune surveillance (80), it remains unknown if CAR-T would efficiently reach senescent cells in the brain parenchyma.”
BackgroundPediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations
Aggarwal, P., Luo, W., Pehlivan, K. C., Hoang, H., Rajappa, P., Cripe, T. P., Cassady, K. A., Lee, D. A., & Cairo, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038096 · Cited by 62
Cell therapy for neurological disorders
Svendsen, S. P., & Svendsen, C. N. (2024) · Nature Medicine · doi:10.1038/s41591-024-03281-3 · Cited by 58
“There is also growing evidence that some level of continual immune surveillance occurs in the brain, especially after inflammatory events, such as an infusion of cells 136 .”
Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity
Hermans, D., Houben, E., Baeten, P., Slaets, H., Janssens, K., Hoeks, C., Hosseinkhani, B., Duran, G., Bormans, S., Gowing, E., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02445-0 · Cited by 53
“1 3 Here, we report that OSM induces BBB disruption in resting and inflamed cells, shown by reduced TEER values due to downregulation of claudin-5 and VE-cadherin expression, two essential cell–cell junctions at the BBB [38, 41, 56].”
BackgroundInfluentialChimeric antigen receptor macrophages target and resorb amyloid plaques
Kim, A. B., Xiao, Q., Yan, P., Pan, Q., Pandey, G., Grathwohl, S., Gonzales, E. R., Xu, I., Cho, Y., Haecker, H., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.175015 · Cited by 55
“…to make room for new cells to engraft — presumably promotes peripheral monocyte infiltration into the brain due to disruption of entry sites into the CNS, including the blood-brain barrier, and promotes increased secretion of cytokines and chemokines that recruit peripheral immune cells (41, 42).”
BackgroundRodrigues, R. O., Shin, S.-R., & Bañobre-López, M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02720-0 · Cited by 44
“Indeed, the immune system has a synergetic and preponderant role in the regulation of the BBB, and vice-versa, which affects the CNS during health and disease [72].”
BackgroundMethodInfluentialEnhancing T Cell Chemotaxis and Infiltration in Glioblastoma
Singh, K., Hotchkiss, K. M., Patel, K. K., Wilkinson, D. S., Mohan, A. A., Cook, S. L., & Sampson, J. H. (2021) · Cancers · doi:10.3390/cancers13215367 · Cited by 53
The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology
Amoriello, R., Memo, C., Ballerini, L., & Ballerini, C. (2024) · Molecular Brain · doi:10.1186/s13041-024-01077-7 · Cited by 54
Biomaterial strategies for regulating the neuroinflammatory response
Galindo, A. N., Rubio, D. A. F., & Hettiaratchi, M. H. (2024) · Materials Advances · doi:10.1039/d3ma00736g · Cited by 50
“50,92 The extent of BBB damage depends on the severity of injury and magnitude of subsequent inflammatory events.”
BackgroundCakmak, P., Lun, J. H., Singh, A., Macas, J., Schupp, J., Schuck, J., Mahmoud, Z., Köhler, M. I., Starzetz, T., Burger, M. C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.09.018 · Cited by 50
Dynamic modulation of the blood–brain barrier in the healthy brain
Friedman, A., Prager, O., Serlin, Y., & Kaufer, D. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00976-5 · Cited by 52
Fetsko, A. R., Sebo, D. J., Budzynski, L. B., Scharbarth, A., & Taylor, M. R. (2024) · iScience · doi:10.1016/j.isci.2024.109651 · Cited by 54
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Montoya, M., Gallus, M., Phyu, S. M., Haegelin, J., de Groot, J., & Okada, H. (2024) · Cells · doi:10.3390/cells13090726 · Cited by 48
“…that disruption of the glia limitans occurs in a similar manner, as it has been observed with conventional T cells via the production of matrix metalloproteinases (MMP) 9 and 2 by recruited myeloid cells resulting in the selective cleavage of dystroglycan on the astrocyte foot-process [40,48,49].”
BackgroundMarchetti, L., Francisco, D. M. F., Soldati, S. G., Jahromi, N. H., Barcos, S., Gruber, I., Pareja, J. R., Thiriot, A., von Andrian, U. H., Deutsch, U., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149238 · Cited by 42
“T-cell diapedesis across the BBB occurs via two different pathways: paracellular, via the endothelial cell-to-cell contacts between adjacent endothelial cells, or transcellular, via a pore through the endothelial cell body itself [6].”
Huang, J., Li, Y. B., Charlebois, C., Nguyen, T., Liu, Z., Bloemberg, D., Zafer, A., Baumann, E., Sodja, C., Leclerc, S., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00342-y · Cited by 43
Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
van de Walle, T., Vaccaro, A., Ramachandran, M., Pietilä, I., Essand, M., & Dimberg, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.724739 · Cited by 41
“Infiltration of T cells across the BBB depends on the multistep process of lymphocyte diapedesis, mediating capture, rolling, adhesion and transendothelial migration, and subsequent re-activation of T cells by APCs in the perivascular space in order to cross the glia limitans [reviewed in (24)].”
BackgroundRole of Dendritic Cells in Viral Brain Infections
Constant, O., Maarifi, G., Blanchet, F. P., Van de Perre, P., Simonin, Y., & Salinas, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862053 · Cited by 35
“Indeed, during activation and arrest steps, migration of mature DCs across the BBB can be enhanced by interaction of CCR7 with CCL19 and CCL21 (Figure 3B), whereas immature DCs can also be attracted by CCR2, CCR3, and CCR5, which interact with CCL2, CCL3, and CCL5, respectively (Figure 3C) (6, 104).”
BackgroundPuvogel, S., Alsema, A. M., Kracht, L., Webster, M. J., Weickert, C. S., Sommer, I. E., & Eggen, B. J. L. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01796-0 · Cited by 39
“Table 4), suggesting their involvement in the regulation of brain vascular capture and permeability to circulating immune cells [29, 68].”
BackgroundHughes, F. M., Odom, M. R., Cervantes, A., Livingston, A. J., & Purves, J. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032821 · Cited by 34
CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis
Clarkson, B. D. S., Grund, E. M., Standiford, M. M., Mirchia, K., Westphal, M. S., Muschler, L. S., & Howe, C. L. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162788 · Cited by 36
“Immune surveillance of CNS-restricted antigens remains incompletely understood (44, 45).”
BackgroundPramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 39
Metabolic Endotoxemia: From the Gut to Neurodegeneration
Chmielarz, M., Sobieszczańska, B., & Środa-Pomianek, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137006 · Cited by 38
Neuroinflammation Associated With Inborn Errors of Immunity
Lindahl, H., & Bryceson, Y. T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.827815 · Cited by 38
Gil, E., Venturini, C., Stirling, D. R., Turner, C. T., Tezera, L. B., Ercoli, G., Baker, T., Best, K., Brown, J., & Noursadeghi, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935798 · Cited by 40
“The entry of leukocytes into the CNS is tightly regulated compared to other tissues, with minimal neutrophil trafficking under basal conditions (14, 15).”
BackgroundImmune response in retinal degenerative diseases – Time to rethink?
Xu, H., & Chen, M. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102350 · Cited by 35
“The Prpf8 gene that causes autosomal dominant RP (Maubaret et al., 2011) is also highly expressed in other retinal cells including bipolar, amacrine and glial cells (Fig.”
BackgroundAlkahtani, S. H., AL–Johani, N. S., & Alarifi, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021340 · Cited by 39
Brain vasculature disturbance in schizophrenia
Puvogel, S., Palma, V., & Sommer, I. E. (2022) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000789 · Cited by 32
The origin of brain malignancies at the blood–brain barrier
McDonald, B., Barth, K., & Schmidt, M. H. H. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04934-1 · Cited by 31
“Importantly, along with the innate immunity of the CNS, peripheral immune cells are also directly involved in the regulation and permeability of the BBB both in health and disease [65, 66].”
BackgroundBlood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions
Wang, J., Zhang, F., Wang, X., Zhang, J., Han, M., & Fei, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030873 · Cited by 41
“This is mediated by the upregulation of adhesion molecules like Vascular and Intercellular Cell Adhesion Molecules (VCAM1 and ICAM1), as well as P-selectin and E-selectin [20–22].”
Boeri, L., Perottoni, S., Izzo, L., Giordano, C., & Albani, D. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002043 · Cited by 28
Vanbilloen, W. J. F., Rechberger, J. S., Anderson, J. B., Nonnenbroich, L. F., Zhang, L., & Daniels, D. J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071804 · Cited by 36
Escobar, A. P., Bonansco, C., Cruz, G., Dagnino‐Subiabre, A., Fuenzalida, M., Negrón-Oyarzo, I., Sotomayor‐Zárate, R., Martínez-Pinto, J., & Jorquera, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210083 · Cited by 38
Immune cells: potential carriers or agents for drug delivery to the central nervous system
Zhang, S., Li, R.-Q., Chen, Z., Wang, X., Dumont, A. S., & Fan, X. (2024) · Military Medical Research · doi:10.1186/s40779-024-00521-y · Cited by 49
“Concurrently, the BBB becomes disrupted, allowing peripheral immune cells to access the diseased brain [10].”
BackgroundStem Cell Therapy for Repair of the Injured Brain: Five Principles
Rust, R., & Tackenberg, C. (2022) · The Neuroscientist · doi:10.1177/10738584221110100 · Cited by 25
“In recent years, several mechanisms have been identified that allow endogenous peripheral immune cells (e.g., neutrophils, lymphocytes, dendritic cells) to cross the intact and damaged BBB (Marchetti and Engelhardt 2020).”
BackgroundTraumatic brain injury: Bridging pathophysiological insights and precision treatment strategies
Lu, Y., Jin, J., Zhang, H., Lu, Q., Zhang, Y., Liu, C., Liang, Y., Tian, S., Zhao, Y., & Fan, H. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01398 · Cited by 32
“A small number of immune cells can cross the BBB through specific mechanisms for immune surveillance (Marchetti and Engelhardt, 2020; Proulx and Engelhardt, 2022).”
Sepehrinezhad, A., Larsen, F. S., Ahmadabad, R. A., Shahbazi, A., & Negah, S. S. (2023) · Cells · doi:10.3390/cells12070979 · Cited by 25
Microfluidic models of the neurovascular unit: a translational view
Wevers, N. R., & de Vries, H. E. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00490-9 · Cited by 28
“Impaired barrier function is often accompanied by endothelial inflammation, thereby facilitating infiltration of circulating immune cells into the CNS [23–25].”
BackgroundAdvancing brain barriers RNA sequencing: guidelines from experimental design to publication
Francisco, D. M. F., Marchetti, L., Rodríguez‐Lorenzo, S., Frías-Anaya, E., de Figueiredo, R. M., BtRAIN Network, Heymans, M., Culot, M., Santa-Maria, A. R., Deli, M. A., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00207-2 · Cited by 31
Robert, S. M., Reeves, B. C., Marlier, A., Duy, P. Q., DeSpenza, T., Kundishora, A. J., Kiziltug, E., Singh, A. K., Allington, G., Alper, S. L., et al. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05255-z · Cited by 26
Constant, O., Maarifi, G., Barthelemy, J., Martin, M. F., Tinto, B., Savini, G., de Perre, P. V., Nisole, S., Simonin, Y., & Salinas, S. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2156815 · Cited by 27
“(CAMs) on CNS barriers that will allow cell attachment and transmigration [15].”
BackgroundThe immunology of brain tumors
Bunse, L., Bunse, T., Kilian, M., Quintana, F. J., & Platten, M. (2025) · Science Immunology · doi:10.1126/sciimmunol.ads0449 · Cited by 31
The emergence of the calvarial hematopoietic niche in health and disease
Mills, W. A., Coburn, M., & Eyo, U. B. (2022) · Immunological Reviews · doi:10.1111/imr.13120 · Cited by 25
Zong, B., Yu, F., Zhang, X., Zhao, W., Li, S., & Li, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1260663 · Cited by 25
Blood-brain barrier biomarkers
Zapata-Acevedo, J. F., Mantilla-Galindo, A., Vargas-Sánchez, K., & González-Reyes, R. E. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.004 · Cited by 28
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
Houssaini, A. S., Lamrabet, S., Nshizirungu, J. P., Senhaji, N., Sekal, M., Karkouri, M., & Bennis, S. (2024) · Vaccines · doi:10.3390/vaccines12060655 · Cited by 28
Engler-Chiurazzi, E. B. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1360242 · Cited by 32
Gonzalez-Fierro, C., Fonte, C., Dufourd, E., Cazaentre, V., Aydin, S., Engelhardt, B., Caspi, R. R., Xu, B., Martin‐Blondel, G., Spicer, J. A., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200117 · Cited by 24
Saikia, B. B., Bhowmick, S., Malat, A., Rani, M. R. P., Thaha, A., & Muneer, P. M. A. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1742-23.2024 · Cited by 28
Treatment advances in high-grade gliomas
Chen, X., Cui, Y., & Zou, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1287725 · Cited by 30
Lorenz, L. M., Hirmer, S., Schmalen, A., Hauck, S. M., & Deeg, C. A. (2021) · Cells · doi:10.3390/cells10030711 · Cited by 26
Smith-Cohn, M., Burley, N. B., & Grossman, S. A. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20999220131163504 · Cited by 21
“The BBB regulates immune cell trafficking into the brain, affecting the efficacy of immunotherapy in primary and metastatic brain cancers [22, 23].”
Bystanders or not? Microglia and lymphocytes in aging and stroke
Chauhan, A., & Nguyen, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.360345 · Cited by 24
“Recent studies have derailed the conventional wisdom that CNS is immuneprivileged tissue and peripheral immune cells only invade the brain when there is damage to the BBB.”
BackgroundInfluentialKim, J., Yoon, T., Kim, P., Bekhbat, M., Kang, S. M., Rho, H. S., Ahn, S. I., & Kim, Y. (2023) · Lab on a Chip · doi:10.1039/d3lc00124e · Cited by 24
Targeting Neutrophil β2-Integrins: A Review of Relevant Resources, Tools, and Methods
Conley, H. E., & Sheats, M. K. (2023) · Biomolecules · doi:10.3390/biom13060892 · Cited by 22
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis
Hartung, H., Cree, B., Barnett, M. H., Meuth, S. G., Bar‐Or, A., & Steinman, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1290666 · Cited by 23
Tension at the gate: sensing mechanical forces at the blood–brain barrier in health and disease
Hansen, C. E., Hollaus, D., Kamermans, A., & de Vries, H. E. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03321-2 · Cited by 22
Three-photon microscopy: an emerging technique for deep intravital brain imaging
Prevedel, R., Ortas, J. F., Kerr, J. N. D., Waters, J., Breckwoldt, M. O., Deneen, B., Monje, M., Soyka, S. J., & Venkataramani, V. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00937-y · Cited by 30
“Deep 2PM has revealed previously unknown aspects of immune cell trafficking in neuroinflammatory conditions 69,108,109 .”
Soldati, S. G., Bär, A., Vladymyrov, M., Glavin, D., McGrath, J. L., Gosselet, F., Nishihara, H., Goelz, S. E., & Engelhardt, B. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02797-8 · Cited by 28
“These observations confirm that α4β1-integrin-VCAM-1 interactions mediate shear resistant arrest of CD4+ T cells to the BBB [74–76], while post-arrest behavior of CD4+ T cells on the BBB is rather mediated by αLβ2-integrin engaging endothelial ICAM-1 and ICAM-2 [54, 78].”
BackgroundInfluentialEnterovirus A71 crosses a human blood–brain barrier model through infected immune cells
Gaume, L., Chabrolles, H., Bisseux, M., Coqueiro, I. L., Dehouck, L., Mirand, A., Henquell, C., Gosselet, F., Archimbaud, C., & Bailly, J. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00690-24 · Cited by 20
“Another reported pathway for viruses to reach the human brain parenchyma is via paracellular (or even transcellular) diapedesis of infected immune cells trafficking from the blood across the BBB (38, 39).”
B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
Chunder, R., Schropp, V., & Küerten, S. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.591894 · Cited by 24
Composite immune marker scores associated with severe mental disorders and illness course
Ormerod, M. B. E. G., Ueland, T., Werner, M. C. F., Hjell, G., Rødevand, L. N., Sæther, L. S., Lunding, S. H., Johansen, I. T., Ueland, T., Lagerberg, T. V., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100483 · Cited by 20
Beyond the blood–brain barrier: unraveling T cell subsets in CNS immunity and disease
Shokr, M. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01955-z · Cited by 26
“But in the setting of CNS inflammation, injury, or illness, these barriers are frequently broken, allowing T cell transmigration to occur, which can have a significant impact on the course of the illness (Marchetti and Engelhardt 2020).”
Neuroimmune signaling at the brain borders
Frederick, N. M., Tavares, G. A., & Louveau, A. (2022) · Immunological Reviews · doi:10.1111/imr.13126 · Cited by 20
Samuels, J. D., Lotstein, M. L., Lehmann, M. L., ELKAHLOUN, A. G., Banerjee, S., & Herkenham, M. A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02827-5 · Cited by 18
“Additionally, our work highlights an enrichment in venous EC-specific interferon gamma signaling, further supporting that these cells exhibit alterations in vascular permeability [57] in response to CSD and may serve as a site of peripheral immune cell entry into the brain and perivascular spaces [58].”
BackgroundMartinez, P. J., Song, J. J., Garay, F. G., Song, K.-H., Mufford, T., Steiner, J., DeSisto, J. A., Ellens, N. P. K., Serkova, N. J., Green, A. L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67916-8 · Cited by 21
Molecular profiling of brain endothelial cell to astrocyte endfoot communication in mouse and human
Hill, S. A., Bravo‐Ferrer, I., Čiulkinytė, A., Ramos, N. P., Rossetti, I., Colvin, C., Beltran-Lobo, P., Parra-Pérez, C., Emelianova, K., Dando, O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65487-4 · Cited by 21
Pfeiffer, F. (2022) · Cells · doi:10.3390/cells11121954 · Cited by 19
Metadata
- Authors
- Marchetti, L., & Engelhardt, B.
- Affiliations
- University of Bern (CH)
- Corresponding author
- Engelhardt, Britta
- ORCID
- Engelhardt, Britta
- Venue
- Vascular Biology
- Publisher
- Bioscientifica
- Published
- 2020-04-10
- Volume
- 2
- Issue
- 1
- Pages
- H1-H18
- ISSN
- 2516-5658 (ISSN-L)
- PMC
- PMC7439848
- OpenAlex
- W3011626148
- Cited by
- 304
- References
- 154
- Citations by year
- 2026: 47 · 2025: 65 · 2024: 64 · 2023: 48 · 2022: 44 · 2021: 29 · 2020: 7
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Vascular Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open Access CRIS of the University of Bern
- Funders
- University of Bern
- Horizon 2020 Framework Programme (H2020‐MSCA‐ITN‐2015, H2020-MSCA, 675619, H2020-MSCA-ITN-2015 675619, H2020-MSCA-ITN)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- blood-brain barrier, immune cell trafficking, neuroinflammation, immune surveillance, endothelial cells, immune cell extravasation, adhesion molecules, immune privilege, in vivo imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.